Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Teva Pharmaceutical
Pharma
Teva, Samsung Bioepis deepen biosimilar bonds with new deal
Already sharing the load on two biosimilar assets, Teva Pharmaceutical and Samsung Bioepis have elected to take their partnership to the next level.
Fraiser Kansteiner
Oct 2, 2026 10:00am
White House unveils next round of MFN drug pricing deals
Aug 31, 2026 5:10pm
Fierce Biotech
Teva saddles up as bidder for bankrupt BioXcel’s CNS assets
Aug 28, 2026 9:17am
Teva's patent and communications strategies in Turkey face probe
Aug 26, 2026 8:15am
Aurinia deal with Teva keeps Lupkynis generic in check until '36
Aug 20, 2026 11:28am
J&J’s Tremfya remains on top in Q2 pharma ad spending league
Jul 21, 2026 9:10am
Fierce Biotech
Fierce Biotech
Fierce Biotech
Fierce Biotech
